Journal
JOURNAL OF PATHOLOGY
Volume 234, Issue 4, Pages 538-547Publisher
WILEY
DOI: 10.1002/path.4418
Keywords
Nrf2; MyoD; ischaemia-reperfusion injury; skeletal muscle
Funding
- START programme [129/10]
- Interdisciplinary Centre for Clinical Research (IZKF) of the Faculty of Medicine of RWTH Aachen University [T9-3, T9-5]
- Deutsche Forschungsgemeinschaft (DFG) [PU 214/3-2, PU 214/4-2, PU 214/5-2]
Ask authors/readers for more resources
Skeletal muscles harbour a resident population of stem cells, termed satellite cells (SCs). After trauma, SCs leave their quiescent state to enter the cell cycle and undergo multiple rounds of proliferation, a process regulated by MyoD. To initiate differentiation, fusion and maturation to new skeletal muscle fibres, SCs up-regulate myogenin. However, the regulation of these myogenic factors is not fully understood. In this study we demonstrate that Nrf2, a major regulator of oxidative stress defence, plays a role in the expression of these myogenic factors. In both promoter studies with myoblasts and a mouse model of muscle injury in Nrf2-deficient mice, we show that Nrf2 prolongs SC proliferation by up-regulating MyoD and suppresses SC differentiation by down-regulating myogenin. Moreover, we show that IL-6 and HGF, both factors that facilitate SC activation, induce Nrf2 activity in myoblasts. Thus, Nrf2 activity promotes muscle regeneration by modulating SC proliferation and differentiation and thereby provides implications for tissue regeneration.Copyright (c) 2014 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available